642 related articles for article (PubMed ID: 31144480)
21. Resistance pattern of breakthrough urinary tract infections in children on antibiotic prophylaxis.
Nateghian AR; Robinson JL; Mohandessi S; Hooman N
J Infect Public Health; 2009; 2(3):147-52. PubMed ID: 20701875
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for new renal scarring in children with vesicoureteral reflux receiving continuous antibiotic prophylaxis.
Su D; Zhuo Z; Zhang J; Zhan Z; Huang H
Sci Rep; 2024 Jan; 14(1):1784. PubMed ID: 38245620
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic prophylaxis for childhood urinary tract infection: a national survey.
Chevalier I; Benoît G; Gauthier M; Phan V; Bonnin AC; Lebel MH
J Paediatr Child Health; 2008 Oct; 44(10):572-8. PubMed ID: 19012629
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic prophylaxis in children with relapsing urinary tract infections: review.
Mangiarotti P; Pizzini C; Fanos V
J Chemother; 2000 Apr; 12(2):115-23. PubMed ID: 10789549
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study.
Roussey-Kesler G; Gadjos V; Idres N; Horen B; Ichay L; Leclair MD; Raymond F; Grellier A; Hazart I; de Parscau L; Salomon R; Champion G; Leroy V; Guigonis V; Siret D; Palcoux JB; Taque S; Lemoigne A; Nguyen JM; Guyot C
J Urol; 2008 Feb; 179(2):674-9; discussion 679. PubMed ID: 18082208
[TBL] [Abstract][Full Text] [Related]
26. Impact of Long-Term Low Dose Antibiotic Prophylaxis on Gut Microbiota in Children.
Akagawa Y; Kimata T; Akagawa S; Yamaguchi T; Kato S; Yamanouchi S; Hashiyada M; Akane A; Kino M; Tsuji S; Kaneko K
J Urol; 2020 Dec; 204(6):1320-1325. PubMed ID: 32614253
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic prophylaxis and recurrent urinary tract infection in children.
Craig JC; Simpson JM; Williams GJ; Lowe A; Reynolds GJ; McTaggart SJ; Hodson EM; Carapetis JR; Cranswick NE; Smith G; Irwig LM; Caldwell PH; Hamilton S; Roy LP;
N Engl J Med; 2009 Oct; 361(18):1748-59. PubMed ID: 19864673
[TBL] [Abstract][Full Text] [Related]
28. Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy.
Prelog M; Schiefecker D; Fille M; Wurzner R; Brunner A; Zimmerhackl LB
Pediatr Nephrol; 2008 Apr; 23(4):597-602. PubMed ID: 18193296
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic prophylaxis for vesicoureteral reflux--answers, yet questions.
Ingelfinger JR; Stapleton FB
N Engl J Med; 2014 Jun; 370(25):2440-1. PubMed ID: 24795143
[No Abstract] [Full Text] [Related]
30. Laboratory Findings After Urinary Tract Infection and Antimicrobial Prophylaxis in Children With Vesicoureteral Reflux.
Nadkarni MD; Mattoo TK; Gravens-Mueller L; Carpenter MA; Ivanova A; Moxey-Mims M; Greenfield SP; Mathews R
Clin Pediatr (Phila); 2020 Mar; 59(3):259-265. PubMed ID: 31888378
[TBL] [Abstract][Full Text] [Related]
31. Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux.
Arlen AM; Alexander SE; Wald M; Cooper CS
J Pediatr Urol; 2016 Oct; 12(5):288.e1-288.e5. PubMed ID: 27072485
[TBL] [Abstract][Full Text] [Related]
32. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY
J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872
[TBL] [Abstract][Full Text] [Related]
33. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.
Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605
[TBL] [Abstract][Full Text] [Related]
34. Incidence of new renal parenchymal inflammatory changes following breakthrough urinary tract infection in patients with vesicoureteral reflux treated with antibiotic prophylaxis: evaluation by 99MTechnetium dimercapto-succinic acid renal scan.
Szlyk GR; Williams SB; Majd M; Belman AB; Rushton HG
J Urol; 2003 Oct; 170(4 Pt 2):1566-8; discussion 1568-9. PubMed ID: 14501662
[TBL] [Abstract][Full Text] [Related]
35. Predicting factors of breakthrough infection in children with primary vesicoureteral reflux.
Jang HC; Park YJ; Park JS
Yonsei Med J; 2012 Jul; 53(4):748-52. PubMed ID: 22665341
[TBL] [Abstract][Full Text] [Related]
36. Controversy in urinary tract infection management in children: a review of new data and subsequent changes in guidelines.
Kari JA; Tullus K
J Trop Pediatr; 2013 Dec; 59(6):465-9. PubMed ID: 23812014
[TBL] [Abstract][Full Text] [Related]
37. Interventions for primary vesicoureteric reflux.
Nagler EV; Williams G; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2011 Jun; (6):CD001532. PubMed ID: 21678334
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for breakthrough urinary tract infection in children with vesicoureteral reflux receiving continuous antibiotic prophylaxis.
Su D; Shen Q; Zhai Y; Chen J; Rao J; Miao Q; Tang X; Zhang Z; Liu J; Liu J; Xu H; Fang X
Transl Pediatr; 2022 Jan; 11(1):1-9. PubMed ID: 35242647
[TBL] [Abstract][Full Text] [Related]
39. Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux.
Nakamura M; Moriya K; Mitsui T; Tanaka H; Nonomura K
J Urol; 2009 Oct; 182(4 Suppl):1694-7. PubMed ID: 19692059
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.
Morello W; Baskin E; Jankauskiene A; Yalcinkaya F; Zurowska A; Puccio G; Serafinelli J; La Manna A; Krzemień G; Pennesi M; La Scola C; Becherucci F; Brugnara M; Yuksel S; Mekahli D; Chimenz R; De Palma D; Zucchetta P; Vajauskas D; Drozdz D; Szczepanska M; Caliskan S; Lombet J; Minoli DG; Guarino S; Gulleroglu K; Ruzgiene D; Szmigielska A; Barbi E; Ozcakar ZB; Kranz A; Pasini A; Materassi M; De Rechter S; Ariceta G; Weber LT; Marzuillo P; Alberici I; Taranta-Janusz K; Caldas Afonso A; Tkaczyk M; Català M; Cabrera Sevilla JE; Mehls O; Schaefer F; Montini G;
N Engl J Med; 2023 Sep; 389(11):987-997. PubMed ID: 37702442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
